On paper, 2026 was a blockbuster year for IPOs: roughly $111 billion raised across 76 deals, up about 625% from 2025 and the biggest haul since the 2021 peak. But there's a catch that reshapes the entire story — SpaceX's record-shattering $75B debut accounts for roughly 67% of all 2026 IPO proceeds on its own.
Strip out that single deal and the other 75 IPOs raised about $36B combined — actually below 2025's full-year pace. This dashboard tracks every notable 2026 IPO with its raise, debut valuation, first-day pop, and sector, so you can see the real shape of the market underneath the headline number.
SpaceX shows how much one listing can move a year's total. It priced at $135 a share on June 11, 2026, which valued the company at about $1.77 trillion, per KeepTrack, and raised roughly $75 billion in the base deal. It opened at $150 and closed its first day at $161.11, up 19.34%, per GREY Journal. Counting the overallotment, KeepTrack lists 638.9 million Class A shares sold and $85.7 billion in net proceeds, the largest IPO on record.
The pipeline holds the next chapter, and it is not priced yet. Anthropic submitted a draft S-1 privately on June 1, 2026 and filed its public S-1 on October 26, 2026, applying to list its Class A common stock on Nasdaq under the symbol ANT, per LeverageShares. The filing reports revenue of $16.29 billion and a net loss of $80.7 billion for the six months ended June 30, 2026, per MEXC. Anthropic amended that S-1 on November 2, 2026 to add Q3 2026 results: revenue of $17.0 billion, up 1,127% year over year, and a swing to a $567 million GAAP operating loss, after Q2's $974 million operating income, driven mainly by $5.0 billion of short-term compute and $2.0 billion of non-cash donation-matching charges. Nine-month 2026 net loss reached $104.0 billion on $33.2 billion of revenue. The price range is still blank. The Wall Street Journal reported a target of the week of November 16, and fifteen days after the public filing is November 10, the earliest a roadshow can start. Neither date comes from Anthropic. OpenAI confidentially submitted a draft S-1 on June 8, 2026, but Sam Altman told Fortune in September 2026, "I would say not 2026."
Every notable IPO that priced in 2026 — from SpaceX and Cerebras to the biotech wave (Veradermics, Kailera, Hemab), crypto (BitGo), quantum (Quantinuum) and the flops (Presto-style SPAC busts). Plus the pipeline of trillion-dollar names still on the runway, and the 2025 class for context. Sortable by raise or first-day pop, filterable by sector.
Priced, postponed and pipeline names sit in separate groups, so a filing is never counted as a listing. Market totals published by different IPO trackers rarely match, because each uses its own inclusion rules (minimum deal size, whether SPACs, direct listings and foreign secondary listings count), so compare this page's notable-deal totals with full-market counts only after checking the threshold behind each. Pipeline entries move to the priced group only after an offer price is set. Updated November 2, 2026: Anthropic's status reflects its amended S-1 (Q3 2026 results). SpaceX figures re-verified against KeepTrack and GREY Journal. Figures are rechecked after each pricing week.